Subsidiary of ApicHope Pharmaceutical Group (300723.SZ) obtains registration certificate for Injection of New Simec Met.
Statement from Yiping Hong (stock code: 300723.SZ): The company's wholly-owned subsidiary, Guangzhou Lianrui Pharmaceutical Co., Ltd., recently received a notice from the national...
ApicHope Pharmaceutical Group (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Lianrui Pharmaceuticals Co., Ltd. recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the Thiocholine Sulfate Injection.
The Thiocholine Sulfate Injection is indicated for: anticholinesterase drugs. It is used to antagonize the residual muscle relaxation effects of non-depolarizing neuromuscular blocking agents at the end of surgery, as well as for myasthenia gravis, postoperative functional intestinal gas retention, and urinary retention.
Related Articles
On October 17th, JIUMAOJIU (09922) spent 1.0013 million Hong Kong dollars to repurchase 49.1 thousand shares.
On October 17th, ANTON OILFIELD (03337) spent approximately 5 million Hong Kong dollars to buy back 449.2 million shares.
Zkteco Co., Ltd. (301330.SZ) plans to acquire 55% of Longzhiyuan's equity to enrich its product array.
On October 17th, JIUMAOJIU (09922) spent 1.0013 million Hong Kong dollars to repurchase 49.1 thousand shares.
On October 17th, ANTON OILFIELD (03337) spent approximately 5 million Hong Kong dollars to buy back 449.2 million shares.
Zkteco Co., Ltd. (301330.SZ) plans to acquire 55% of Longzhiyuan's equity to enrich its product array.
RECOMMEND
